Atkinson Edward Morrow III

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
7
Insider Sells Sum
$5.33M

Insider Activity of Atkinson Edward Morrow III

According to the SEC Form 4 filings, Atkinson Edward Morrow III, being in a position of

  1. EVP, Chief Technical Ops. Off. at Vertex Pharmaceuticals Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 11086 shares for $5.09M,
    over all time since 2024-02-12, has bought 0 shares, and sold 11086 shares for $5.09M.

The largest sale of all time was on 2024-06-12 and amounted to 7288 shares of Vertex Pharmaceuticals Incorporated for $3.48M.

Biography of Atkinson Edward Morrow III

No biography is available at this moment.

2024-06-12SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Technical Ops. Off.
7,288
0.0028%
$478.00$3.48M-0.38%
2024-02-26SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Technical Ops. Off.
883
0.0003%
$425.70$375,893+7.16%
2024-02-21SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Technical Ops. Off.
1,201
0.0005%
$421.77$506,546+10.6%
2024-02-20SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Technical Ops. Off.
801
0.0003%
$420.79$337,053+10.32%
2024-02-12SaleVertex Pharmaceuticals Incorporated
VRTX
EVP, Chief Technical Ops. Off.
913
0.0004%
$420.24$383,679+10.6%
2023-06-01Sale89bio, Inc.
ETNB
director
6,250
0.0112%
$17.91$111,938-41.25%
2023-03-01Sale89bio, Inc.
ETNB
director
10,000
0.0184%
$13.60$136,000+8.33%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.